January 15, 2021
Checkmate Pharmaceuticals has once again partnered with The Chase Group to continue building its team of life sciences entrepreneurs who are devoted to discovering and developing novel approaches to fighting cancer. The company is enthusiastic as they advance their lead asset toward registration and expand toward potential proof of concept in additional indications. Checkmate has retained The Chase Group to identify a Head of Regulatory Affairs to serve as the team’s regulatory expert while developing and implementing their global regulatory strategies. This high-profile position provides an incredible opportunity for growth while demonstrating the potential of activating the immune system to fight cancer and improve patient outcomes. Through our vast network of regulatory leaders, The Chase Group is poised to identify the high caliber talent to join Checkmate in its mission to checkmate cancer. Find out more about The Chase Group’s executive search services by emailing moira@chasegroup.com
